Mereo BioPharma (MREO) Other Working Capital Changes (2023 - 2026)
Mereo BioPharma (MREO) posted quarterly Other Working Capital Changes of -$201000.0 for Q1 2026, down 18.24% year-over-year from -$245827.3 in Q1 2025, and down 3.61% quarter-over-quarter from -$194000.0 in Q4 2025.
Mereo BioPharma (MREO) Other Working Capital Changes (2023 - 2026) Analysis & Trends
Mereo BioPharma (MREO) has reported Other Working Capital Changes for 4 consecutive years, with -$201000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Working Capital Changes fell 18.24% year-over-year to -$201000.0; the TTM figure through Mar 2026 stood at -$774000.0 (down 15.87% YoY), while the FY2025 annual figure was -$743000.0, down 13.61% from the prior year.
- Other Working Capital Changes fell to -$201000.0 in Q1 2026 per MREO's latest filing, from -$194000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $9.4 million in Q2 2023 and bottomed at -$8.5 million in Q3 2023.
- Historically, Other Working Capital Changes has averaged -$282230.8 across 4 years, with a median of -$235000.0 in 2025.
- On a YoY basis, Other Working Capital Changes climbed as much as 8.97% in 2025 and fell as far as 19.38% in 2025.
- Mereo BioPharma's Other Working Capital Changes stood at -$150000.0 in 2023, then declined by 13.33% to -$170000.0 in 2024, then retreated by 14.12% to -$194000.0 in 2025, then dropped by 3.61% to -$201000.0 in 2026.
- Business Quant data shows MREO's Other Working Capital Changes at -$201000.0 in Q1 2026, -$194000.0 in Q4 2025, and -$188000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Mereo BioPharma | 47.39 Mn | 47.39 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1,000.00 |
| Jun 30, 2026 | 1,000.00 |
| Jun 30, 2026 | 1,000.00 |
| Mar 31, 2026 | -201,000.00 |
| Mar 31, 2026 | -201,000.00 |
| Mar 31, 2026 | -201,000.00 |
| Dec 31, 2025 | -194,000.00 |
| Dec 31, 2025 | -194,000.00 |
| Dec 31, 2025 | -194,000.00 |
| Sep 30, 2025 | -188,000.00 |
| Sep 30, 2025 | -188,000.00 |
| Sep 30, 2025 | -188,000.00 |
| Jun 30, 2025 | -191,000.00 |
| Jun 30, 2025 | -191,000.00 |
| Jun 30, 2025 | -191,000.00 |
| Mar 31, 2025 | -170,000.00 |
| Mar 31, 2025 | -170,000.00 |
| Mar 31, 2025 | -170,000.00 |
| Dec 31, 2024 | -170,000.00 |
| Dec 31, 2024 | -170,000.00 |